Lung cancer is the one of the most common types of cancer doctors diagnose each year in the U.S. The most common kind of lung cancer is non-small-cell lung cancer (NSCLC). It makes up around 84% ...

Lung cancer is a disease in which cancerous cells form in the tissues around and inside the lung. There are various types of this disease. Non-small cell lung cancer (NSCLC) is a disease where cancer ...

Prognosis depends in part on the type of lung cancer, whether small cell lung cancer or non-small cell lung cancer ... such as lung computed tomography (CT) scans, are able to diagnose cancer ...

Oak Lawn resident Sheila Spane is a lung cancer advocate who lost her mother to lung cancer. On Monday, April 7, Spane will travel to Washington, D.C. to meet with her members of Congress as part of ...

Panelists discuss how the five-year prognosis for advanced non-small cell lung cancer (NSCLC) has improved with PD-1 inhibitors, showing promising overall survival (OS) and progression-free survival ...

In celebration of a decade of powerful advocacy and progress, Rison resident and lung cancer survivor, Melinda McKnight, will travel to Washington, D.C., for the American Lung Association’s 2025 LUNG ...

Among patients with non-small cell lung cancer (NSCLC), treatment with the Janus kinase 1 (JAK1)-only inhibitor golidocitinib with PD-1 antibodies following progression on anti-PD-1 therapy elicited ...

Common symptoms of non-small cell lung cancer (NSCLC) include frequent coughing that worsens over time, chest pain, and shortness of breath. Non-small cell lung cancer (NSCLC) is the most common ...

There are two major types of lung cancers, which can affect smokers and non-smokers alike, small-cell lung cancer and non-small-cell lung cancer. Doctors now recognize it's a group of cancer ...

Non-small cell lung cancer (NSCLC) is the most common type of ... These follow-ups will likely include computed tomography ...

Read more about A trial looking at a drug called UCB4594 for cancer that has spread A trial looking at MK-2870 for non small cell lung cancer (MK-2870-007) This trial is comparing the combination of ...